Cargando…
Antisense Oligonucleotides and RNA Interference
This chapter outlines the progress made to meet delivery challenges and the clinical applications of antisense technology and highlights the limitations of antisense agents in therapeutics. Antisense technology presents an opportunity to manipulate gene expression within cells to treat an endless nu...
Autores principales: | Kher, Gitanjali, Trehan, Sonia, Misra, Ambikanandan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150054/ http://dx.doi.org/10.1016/B978-0-12-384964-9.00007-4 |
Ejemplares similares
-
Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses
por: Spurgers, Kevin B., et al.
Publicado: (2008) -
Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages
por: Calero, Macarena, et al.
Publicado: (2022) -
Improved targeting of miRNA with antisense oligonucleotides
por: Davis, Scott, et al.
Publicado: (2006) -
Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets
por: Barresi, Vincenza, et al.
Publicado: (2022) -
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
por: Gareri, Clarice, et al.
Publicado: (2022)